Accenture, Orexo Team to Offer Digital Therapeutics Through INTIENT™ Platform

NEW YORK and MORRISTOWN, N.J.; Nov. 16, 2020 ‒ Accenture (NYSE: ACN) has helped the U.S. subsidiary of Swedish pharmaceutical company Orexo launch its first digital therapeutic, vorvida®, for patients in the United States dealing with problematic alcohol use. vorvida® is a web-based digital platform that uses the INTIENT™ Patient solution suite, which is powered by Google Cloud, to enable secure patient interactions and connectivity to an ecosystem of third-party health care services.

Comments

Popular posts from this blog

Add Custom Field in Output of Standard Report of ME2N

HANA Housekeeping using HANACleaner

Accenture to Strengthen Oracle Capabilities in the Middle East with AppsPro Acquisition